A STATement on Vemurafenib-Resistant Melanoma

Por Hartsough, Edward J., Aplin, Andrew E.
Publicado em 2013

Of Mice and Melanoma

Por Hartsough, Edward J., Aplin, Andrew E.
Publicado no Clin Cancer Res (2016)

Beneficial Effects of RAF Inhibitor in Mutant BRAF Splice Variant-expressing Melanoma

Por Hartsough, Edward J., Basile, Kevin, Aplin, Andrew E.
Publicado em 2014

Inhibition of mutant BRAF splice variant signaling by next generation, selective RAF inhibitors

Por Basile, Kevin J., Le, Kaitlyn, Hartsough, Edward J., Aplin, Andrew E.
Publicado em 2014

Function-blocking ERBB3 antibody inhibits the adaptive response to RAF inhibitor

Por Kugel, Curtis H., Hartsough, Edward J., Davies, Michael A., Setiady, Yulius Y., Aplin, Andrew E.
Publicado em 2014

In vivo MAPK reporting reveals the heterogeneity in tumoral selection of resistance to RAF inhibitors

Por Basile, Kevin J., Abel, Ethan V., Dadpey, Neda, Hartsough, Edward J., Fortina, Paolo, Aplin, Andrew E.
Publicado em 2013

Lysine Methylation Promotes VEGFR-2 Activation and Angiogenesis

Por Hartsough, Edward J., Meyer, Rosana D., Chitalia, Vipul, Jiang, Yan, Marquez, Victor E., Zhdanova, Irina V., Weinberg, Janice, Costello, Catherine E., Rahimi, Nader
Publicado em 2013